Assessment of brain health in primary care using a tablet-based tool
A Pragmatic Trial of the TabCAT Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
This study is testing a new tablet tool to see if it can help doctors in primary care spots better spot cognitive issues like dementia compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (Pasadena, California) |
| Trial ID | NCT06090578 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the TabCAT Brain Health Assessment, a tablet-based tool designed to detect cognitive impairment, including dementia, in primary care settings. Conducted across 26 Kaiser Permanente Southern California clinics, the trial compares the outcomes of clinics using the TabCAT-BHA paradigm against those providing usual care. The study involves a pragmatic cluster randomized design, with clinics matched based on various demographic and operational factors. Data will be collected from electronic medical records to assess detection rates and other brain health outcomes over an 18-month period.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 65 and older who have had at least one encounter at a participating clinic during the intervention period.
Not a fit: Patients under the age of 18 will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this approach could lead to earlier and more accurate detection of cognitive impairments in primary care settings, improving patient outcomes.
How similar studies have performed: Other studies have shown success with similar tablet-based cognitive assessment tools, indicating potential for effective implementation in primary care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with at least one encounter at an intervention clinic during the intervention period * Age 18+ (limited to 65+ for primary analyses) Exclusion Criteria: * Patients under the age of 18.
Where this trial is running
Pasadena, California
- Kaiser Permanente Southern California Department of Research & Evaluation — Pasadena, California, United States (Recruiting)
Study contacts
- Principal investigator: Katherine Possin, PhD — University of California, San Francisco
- Study coordinator: Collette Goode, BS
- Email: collette.goode@ucsf.edu
- Phone: 415-514-0881
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.